MS drug use in late pregnancy under review: is it safe?
NCT ID NCT06053749
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study checks how many women with multiple sclerosis (MS) used the drug interferon-beta during the second and third trimesters of pregnancy in Finland and Sweden. Researchers want to see if there are enough cases to study whether the drug affects pregnancy outcomes like birth defects or preterm birth. The study uses existing health records from 1996 onward and does not involve any new treatments or direct contact with participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many locations
Multiple Locations, Finland
-
Many locations
Multiple Locations, Sweden
Conditions
Explore the condition pages connected to this study.